Katherine N Weilbaecher Selected Research

Katherine N Weilbaecher Research Topics

Disease

39	Neoplasms (Cancer) 10/2021 - 03/2002
19	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2003
11	Breast Neoplasms (Breast Cancer) 10/2021 - 09/2007
5	Bone Resorption 01/2021 - 04/2010
4	Inflammation (Inflammations) 01/2022 - 11/2009
4	Melanoma (Melanoma, Malignant) 10/2021 - 03/2002
4	Osteolysis 01/2020 - 02/2007
4	Multiple Myeloma 01/2017 - 01/2013
2	Triple Negative Breast Neoplasms 01/2021 - 11/2015
2	Bone Neoplasms (Bone Cancer) 01/2020 - 12/2019
2	Hypercalcemia (Milk Alkali Syndrome) 01/2020 - 09/2017
2	Osteoporosis 02/2013 - 10/2012
1	Glioma (Gliomas) 05/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	COVID-19 01/2022
1	Infections 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Fatty Liver 01/2020
1	T-Cell Leukemia (Leukemia, T Cell) 01/2020
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2019
1	Circulating Neoplastic Cells 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

10	IntegrinsIBA 01/2021 - 11/2003
5	Zoledronic Acid (Zometa)FDA Link 01/2016 - 08/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2012
4	Pharmaceutical PreparationsIBA 01/2020 - 02/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2011
3	Parathyroid Hormone-Related ProteinIBA 01/2021 - 09/2017
3	LipidsIBA 01/2020 - 06/2015
3	Integrin beta3 (GPIIIa)IBA 11/2009 - 11/2003
3	Microphthalmia-Associated Transcription FactorIBA 12/2002 - 03/2002
2	MicellesIBA 01/2021 - 11/2017
2	CalciumIBA 01/2021 - 12/2019
2	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2017
2	Oncogene Proteins (Oncogene Protein)IBA 12/2019 - 06/2015
2	Biological ProductsIBA 12/2019 - 01/2018
2	Lipase (Acid Lipase)FDA Link 01/2016 - 06/2015
2	ProdrugsIBA 01/2016 - 06/2015
2	Clopidogrel (Plavix)FDA Link 12/2013 - 10/2012
2	Integrin alpha4beta1 (VLA-4)IBA 01/2013 - 01/2011
2	RadiopharmaceuticalsIBA 01/2013 - 11/2009
2	LigandsIBA 11/2012 - 02/2012
2	S100 Proteins (S 100 Protein)IBA 12/2002 - 03/2002
2	MART-1 AntigenIBA 12/2002 - 03/2002
1	Temozolomide (Temodar)FDA LinkGeneric 05/2022
1	AnticoagulantsIBA 01/2022
1	CytokinesIBA 01/2022
1	roneparstatIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	VaccinesIBA 01/2022
1	heparanaseIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Arginine (L-Arginine)FDA Link 10/2021
1	ArginaseIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2021
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 09/2021
1	Mast Cell StabilizersIBA 09/2021
1	InterferonsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	RhodaminesIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	LuciferasesIBA 12/2019
1	CopperIBA 06/2019
1	Tumor Biomarkers (Tumor Markers)IBA 06/2019
1	Phosphotransferases (Kinase)IBA 10/2018
1	Molecular Probes (Molecular Probe)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 01/2018
1	CypateIBA 01/2018
1	Basic-Leucine Zipper Transcription FactorsIBA 09/2017
1	Acetates (Acetic Acid Esters)FDA Link 01/2017
1	fumagillinIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	CilengitideIBA 01/2016
1	EpitopesIBA 11/2015
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2015
1	eribulin FDA Link 11/2015
1	POL5551IBA 11/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2013
1	Androgen Receptors (Androgen Receptor)IBA 05/2013
1	AndrogensIBA 05/2013

Therapy/Procedure

18	Therapeutics 05/2022 - 11/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2007
2	Neoadjuvant Therapy 01/2021 - 09/2007
2	Aftercare (After-Treatment) 01/2017 - 11/2009
1	Chronotherapy 05/2022
1	Immunotherapy 10/2021
1	Injections 01/2020
1	Transplantation 01/2020
1	Secondary Prevention 01/2020
1	Precision Medicine 06/2019